Loading
Latest filing published 25 Feb 2019 for NxStage Medical, Inc., €423k.
Jean K. Mixer discloses dealings in NxStage Medical, Inc. to SEC (Form 4). In total, 5 filings cover trades dated from 14 November 2016 to 21 February 2019.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 25 February 2019 with a transaction (€423k) in NxStage Medical, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations